SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-096650
Filing Date
2023-12-19
Accepted
2023-12-19 08:00:24
Documents
13
Period of Report
2023-12-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190298-8k_onconetix.htm   iXBRL 8-K 24744
2 PRESS RELEASE, DATED DECEMBER 19, 2023 ea190298ex99-1_onconetix.htm EX-99.1 11975
  Complete submission text file 0001213900-23-096650.txt   216112

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bwv-20231219.xsd EX-101.SCH 3012
4 XBRL LABEL FILE bwv-20231219_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bwv-20231219_pre.xml EX-101.PRE 22358
7 EXTRACTED XBRL INSTANCE DOCUMENT ea190298-8k_onconetix_htm.xml XML 3409
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231495660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)